AmerisourceBergen Corp. Fourth Quarter Earnings Sneak Peek

S&P 500 (NYSE:SPY) component AmerisourceBergen Corp. (NYSE:ABC) will unveil its latest earnings on Tuesday, November 1, 2011. AmerisourceBergen is a pharmaceutical services company providing drug distribution and related healthcare services to pharmacy, physician, and manufacturer customers based in North America.

AmerisourceBergen Corp. Earnings Preview Cheat Sheet

Wall St. Earnings Expectations: The average estimate of analysts is for net income of 56 cents per share, a rise of 12% from the company’s actual earnings for the same quarter a year ago. The average estimate is the same as three months ago. Between one and three months ago, the average estimate was unchanged. It also has not changed during the last month. Analysts are projecting profit to rise by 18.5% versus last year to $2.56.

Past Earnings Performance: The company has beaten estimates the last four quarters and is coming off a quarter where it topped forecasts by 2 cents, reporting profit of 61 cents per share against a mean estimate of net income of 59 cents per share.

Investing Insights: Here’s Why Chipotle’s Stock Keeps Winning.

Wall St. Revenue Expectations: Analysts are projecting a rise of 2.3% in revenue from the year-earlier quarter to $20.18 billion.

Analyst Ratings: Analysts are bullish on this stock with 12 analysts rating it as a buy, none rating it as a sell and two rating it as a hold.

A Look Back: In the third quarter, profit rose 13% to $184.4 million (66 cents a share) from $163.2 million (57 cents a share) the year earlier, exceeding analyst expectations. Revenue rose 2.9% to $20.16 billion from $19.6 billion.

Key Stats:

The company has seen net income rise in three straight quarters. Net income rose 18.4% in the second quarter and 6.1% in the first quarter.

Revenue has risen the past four quarters. Revenue rose 2.4% in the second quarter from the year earlier, climbed 2.9% in the first quarter from the year-ago quarter and 5.3% in the fourth quarter of the last fiscal year.

Competitors to Watch: McKesson Corporation (NYSE:MCK), Cardinal Health, Inc. (NYSE:CAH), Henry Schein, Inc. (NASDAQ:HSIC), Omnicare, Inc. (NYSE:OCR), BioScrip Inc. (NASDAQ:BIOS), Grupo Casa Saba, S.A. (NYSE:SAB), Owens & Minor, Inc. (NYSE:OMI), Patterson Companies, Inc. (NASDAQ:PDCO), PSS World Medical, Inc. (NASDAQ:PSSI), and MWI Veterinary Supply, Inc. (NASDAQ:MWIV).

Stock Price Performance: During August 2, 2011 to October 26, 2011, the stock price had risen $3.28 (8.7%) from $37.62 to $40.90. The stock price saw one of its best stretches over the last year between December 13, 2010 and December 23, 2010 when shares rose for nine-straight days, rising 9.5% (+$2.95) over that span. It saw one of its worst periods between July 22, 2011 and August 1, 2011 when shares fell for seven-straight days, falling 6.9% (-$2.78) over that span. Shares are up $7.07 (+20.9%) year to date.

(Source: Xignite Financials)

Investing Insights: Here’s Why Chipotle’s Stock Keeps Winning.